Recently, a PKD2-founder variant was identified, accounting for 20% of the PKD2-population in Taiwan. Interestingly, preliminary data indicate that this variant may be frequently present in Europe as well.
In a collaborative project with our Taiwanese colleagues, we at Charité Berlin are compiling a transnational cohort of individuals with this founder variant for joint analyses.

Question Title

* 1. Are you aware of patients with the specific PKD2-mutation (NM_000297.4) c.2407C>T, p.Arg803* in your center?

T